Hui Li
12Patents
5h-index
10Co-inventors
59Inventor score
Filing activity: May 24, 2005 → Apr 30, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7335345B2 | Synthesis of water soluble nanocrystalline quantum dots and uses thereof | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7597870B2 | Water soluble quantum dots | Emerging Cross-Sectional Technologies | 13 | Active |
| US7824653B2 | Water soluble quantum dots | Emerging Cross-Sectional Technologies | 9 | Active |
| US8080229B2 | Water soluble nanocrystalline quantum dots | Emerging Cross-Sectional Technologies | 5 | Active |
| US7976819B2 | Water soluble nanocrystalline quantum dots | Emerging Cross-Sectional Technologies | 5 | Active |
| US8491818B2 | Synthesis of water soluble non-toxic nanocrystalline quantum dots and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US10391181B2 | Cyclodextrin and antibody-drug conjugate formulations | Performing Operations; Transporting | 1 | Active |
| US8865477B2 | Water soluble nanocrystalline quantum dots capable of near infrared emissions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9987374B2 | Cyclodextrin and antibody-drug conjugate formulations | Performing Operations; Transporting | 1 | Active |
| US9846161B2 | Water soluble nanocrystalline quantum dots capable of near infrared emissions | Emerging Cross-Sectional Technologies | 0 | Active |
| US9546317B2 | Synthesis of water soluble non-toxic nanocrystalline quantum dots and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9610361B2 | Cyclodextrin and antibody-drug conjugate formulations | Performing Operations; Transporting | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.